Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Healthtrust
Moodys
Cipla
Baxter
Cantor Fitzgerald
Boehringer Ingelheim
Johnson and Johnson
Novartis

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,629,425

« Back to Dashboard

Summary for Patent: 5,629,425
Title: Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thi ophene
Abstract:The present invention is directed to chemical processes for preparing 2-aryl-6-hydroxy-3-[4-(2-aminoethoxy)benzoyl]benzo[b]thiophenes. The present invention is also directed to crystalline solvates and a non-solvated crystalline form of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thi ophene hydrochloride, as well as processes for their preparation.
Inventor(s): LaBell; Elizabeth S. (Lafayette, IN), McGill; John M. (Lafayette, IN), Miller; Randal S. (Lafayette, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:08/308,325
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 5,629,425

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,629,425

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1068324 ➤ Subscribe
China 1127253 ➤ Subscribe
China 1075069 ➤ Subscribe
Colombia 4410190 ➤ Subscribe
Colombia 4410191 ➤ Subscribe
Costa Rica 5134 ➤ Subscribe
Czech Republic 9502403 ➤ Subscribe
Czech Republic 290343 ➤ Subscribe
Czech Republic 290344 ➤ Subscribe
Czech Republic 9502402 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Cerilliant
Medtronic
AstraZeneca
Covington
Baxter
Deloitte
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot